Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management

Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management

The advent of immunotherapy, specifically of immune checkpoint inhibitors (ICIs), for the treatment of solid tumors has deeply transformed therapeutic algorithms in medical oncology. Approximately one-third of patients treated with ICIs may de velop immune-related adverse events, and the gastrointes...

Full description

Bibliographic Details
Main Authors: Maria Terrin, Giulia Migliorisi, Arianna Dal Buono, Roberto Gabbiadini, Elisabetta Mastrorocco, Alessandro Quadarella, Alessandro Repici, Armando Santoro, Alessandro Armuzzi
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:International Journal of Molecular Sciences
Subjects:
checkpoint inhibitors
colitis
immune-related adverse events
enterocolitis
diarrhea
Online Access:https://www.mdpi.com/1422-0067/24/14/11504

Internet

https://www.mdpi.com/1422-0067/24/14/11504

Similar Items